A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Investigator’s Choice in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
Trial Number
NCT05257408 (ClinicalTrials.gov Identifier)Contact Person
Status
Recruiting
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
GINECO
CEEGOG
GEICO
NCRI
BGOG
ISGO